Paris-based robotics company Wandercraft commercially launched Eve on September 17, 2026, marking the first time an FDA-cleared self-balancing personal robotic knee exoskeleton has been available for home use by eligible wheelchair users with spinal cord injuries.
The FDA granted 510(k) clearance (K260381) for Eve as a Class II medical device in August 2026. That decision was supported by a three-site clinical trial evaluating safety, upright mobility, and usability.
Unlike previous exoskeletons that require crutches or a walker for balance, Eve uses “physical AI,” a system of motorized joints and stabilization algorithms that maintains upright stability automatically, leaving both hands free during movement.
FDA clearance showed that Eve was ready to move forward; today is about making it a reality for the people we built it for.
Matthieu Masselin, co-founder and CEO of Wandercraft
Eve is cleared for adults 18 and older with spinal cord injury at any neurological level, making it the first device in its category without restrictions tied to injury level. Use is intended for level indoor surfaces and immediately adjacent outdoor areas, such as patios, and requires supervision by a specially trained companion.
Practical applications include standing at a kitchen counter, moving through the home, reaching a bathroom sink, and having eye-level conversations. Users direct movement through a handheld controller, triggering actions such as step, stop, and turn.
“With Eve, being upright isn’t just about standing. It’s about having the freedom to use my hands, move through my home, and connect with people in a new way,” said Caroline Laubach, a Wandercraft test pilot, according to Interesting Engineering.
Eve is available through more than 180 National Seating and Mobility locations across the United States. Medicare billing is available under HCPCS code K1007 for users who meet eligibility and medical necessity requirements. Individual coverage depends on each patient’s specific plan. Wandercraft’s dedicated access team assists users and their care teams with evaluation, fitting, reimbursement navigation, and ongoing service. Pricing has not been publicly disclosed.
Wandercraft positions Eve as a complement to the wheelchair rather than a replacement, giving eligible users an additional option for upright mobility at home. Expansion to regions outside the United States is planned to follow the U.S. launch.
